PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells

Experimental Cell Research

Volumn 298, Issue 1, 2004, Pages 296-304

  Shio, Marinatiemi ^a   Ribeiro Dias, Fátima ^b   Timenetsky, Jorge ^a   Jancar, Sonia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

COX 2; iNOS; Macrophages; MAM; Mycoplasma; Nitric oxide; PAF; Prostaglandins; Superantigen

Indexed keywords

BEPAFANT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGENIC AGENT; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NITRIC OXIDE; PROSTAGLANDIN E2; SUPERANTIGEN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; DRUG INHIBITION; IMMUNOBLOTTING; IMMUNOSTIMULATION; MACROPHAGE; MOUSE; MYCOPLASMA; MYCOPLASMA ARTHRITIDIS; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

MURINAE; MYCOPLASMA; MYCOPLASMA ARTHRITIDIS; MYCOPLASMATALES;

EID: 3042783094     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.04.027     Document Type: Article

References (42)

1. Cole B.C. Mycoplasma-induced arthritis in animals: relevance to understanding the etiologies of the human rheumatic diseases. Rev. Rheum. Engl. Ed. 66:1999;45S-49S
2. al-Daccak R., Mehindate K., Poubelle P.E., Mourad W. Signalling via MHC class II molecules selectively induces IL-1 beta over IL-1 receptor antagonist gene expression. Biochem. Biophys. Res. Commun. 201:1994;855-860
3. Brand J.M., Kirchner H., Neustock P., Kruse A. Induction of cytokines in human whole blood cultures by a mitogen derived from Mycoplasma arthritidis and by staphylococcal enterotoxin B. Immunobiology. 186:1992;246-253
4. Rink L., Kirchner H. Mycoplasma arthritidis-derived superantigen. Chem. Immunol. 55:1992;137-145
5. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2:2001;907-916
6. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38:1998;97-120
7. Benveniste J. PAF-acether (platelet-activating factor). Adv. Prostaglandin, Thromboxane, Leukotriene Res. 19:1989;355-358
8. Pettipher E.R., Higgs G.A., Henderson B. PAF-acether in chronic arthritis. Agents Actions. 21:1987;98-103
9. Rocha F.A., Jancar S., Fraga C.A., Timo-Iaria C., De Brum-Fernandes A.J. Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry. J. Rheumatol. 20:1993;1374-1377
10. Crofford L.J., Wilder R.L., Ristimaki A.P., Sano H., Remmers E.F., Epps H.R., Hla T. Cyclooxygenase-1 and-2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J. Clin. Invest. 93:1994;1095-1101
11. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350:1994;9-12
12. Ueki Y., Miyake S., Tominaga Y., Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 23:1996;230-236
13. McCartney-Francis N., Allen J.B., Mizel D.E., Albina J.E., Xie Q.W., Nathan C.F., Wahl S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:1993;749-754
14. Rocha J.C.S., Peixoto M.E., Jancar S., Cunha F.Q., Ribeiro R.A., Rocha F.A. Dual effect of nitric oxide in articular inflammatory pain in zymosan-induced arthritis in rats. Br. J. Pharmacol. 136:2002;588-596
15. Mu H.H., Sawitzke A.D., Cole B.C. Presence of Lps(d) mutation influences cytokine regulation in vivo by the Mycoplasma arthritidis mitogen superantigen and lethal toxicity in mice infected with M. arthritidis. Infect. Immun. 69:2001;3837-3844
16. Ribeiro-Dias F., Shio M.T., Timenetsky J., Oliane A.P., Metran C.C., Pessoa F.B., Jancar S. Mycoplasma arthritidis superantigen (MAM)-induced macrophage nitric oxide release is MHC class ii restricted, interferongamma dependent, and toll-like receptor 4 independent. Exp. Cell Res. 286:2003;345-354
17. Flick D.A., Gifford G.E. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods. 68:1984;167-175
18. Cole B.C., Balderas R.A., Ahmed E.A., Kono D., Theofilopoulos A.N. Genomic composition and allelic polymorphisms influence V beta usage by the Mycoplasma arthritidis superantigen. J. Immunol. 150:1993;3291-3299
19. Perkins D.J., Kniss D.A. Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages. J. Leukocyte Biol. 65:1999;792-799
20. Marnett L.J., Wright T.L., Crews B.C., Tannenbaum S.R., Morrow J.D. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J. Biol. Chem. 275:2000;13427-13430
21. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmacol. 114:1995;1335-1342
22. Clancy R., Varenika B., Huang W., Ballou L., Attur M., Amin A.R., Abramson S.B. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J. Immunol. 165:2000;1582-1587
23. Lin W.W., Chen B.C., Hsu Y.W., Lee C.M., Shyue S.K. Modulation of inducible nitric oxide synthase induction by prostaglandin E2 in macrophages: distinct susceptibility in murine J774 and RAW 264.7 macrophages. Prostaglandins Other Lipid Mediators. 58:1999;87-101
24. D'Acquisto F., Sautebin L., Iuvone T., Di Rosa M., Carnuccio R. Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages. FEBS Lett. 440:1998;76-80
25. Harbrecht B.G., Kim Y.M., Wirant E.A., Simmons R.L., Billiar T.R. Timing of prostaglandin exposure is critical for the inhibition of LPS- or IFN-gamma-induced macrophage NO synthesis by PGE2. J. Leukocyte Biol. 61:1997;712-720
26. Mehindate K., al-Daccak R., Dayer J.M., Kennedy B.P., Kris C., Borgeat P., Poubelle P.E., Mourad W. Superantigen-induced collagenase gene expression in human IFN-gamma-treated fibroblast-like synoviocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2. J. Immunol. 155:1995;3570-3577
27. Hendricks A., Leibold W., Kaever V., Schuberth H.J. Prostaglandin E2 is variably induced by bacterial superantigens in bovine mononuclear cells and has a regulatory role for the T cell proliferative response. Immunobiology. 201:2000;493-505
28. Hauschildt S., Bessler W.G., Scheipers P. Engagement of major histocompatibility complex class II molecules leads to nitrite production in bone marrow-derived macrophages. Eur. J. Immunol. 23:1993;2988-2992
29. Christ E.A., Meals E., English B.K. Streptococcal pyrogenic exotoxins A (SpeA) and C (SpeC) stimulate the production of inducible nitric oxide synthase (iNOS) protein in RAW 264.7 macrophages. Shock. 8:1997;450-453
30. Steil A.A., Garcia Rodriguez M.C., Alonso A., Crespo M.S., Bosca L. Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis. Br. J. Pharmacol. 114:1995;895-901
31. Szabo C., Wu C.C., Mitchell J.A., Gross S.S., Thiemermann C., Vane J.R. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ. Res. 73:1993;991-999
32. Arthur J.F., Shahin S., Dusting G.J. Paf antagonists block induction of nitric oxide synthase in cultured macrophages and vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 22:1995;452-454
33. Lonardoni M.V., Russo M., Jancar S. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect. Immun. 68:2000;6355-6361
34. Yamada M., Tanimoto A., Ichinowatari G., Yaginuma H., Ohuchi K. Possible participation of intracellular platelet-activating factor in tumor necrosis factor-alpha production by rat peritoneal macrophages. Eur. J. Pharmacol. 374:1999;341-350
35. Tsuyuki K., Ichinowatari G., Tanimoto A., Yamada M., Yaginuma H., Ohuchi K. Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. Biochim. Biophys. Acta. 1583:2002;26-34
36. Hwang D., Jang B.C., Yu G., Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem. Pharmacol. 54:1997;87-96
37. Beck K.F., Sterzel R.B. Cloning and sequencing of the proximal promoter of the rat iNOS gene: activation of NFkappaB is not sufficient for transcription of the iNOS gene in rat mesangial cells. FEBS Lett. 394:1996;263-267
38. Trede N.S., Castigli E., Geha R.S., Chatila T. Microbial superantigens induce NF-kappa B in the human monocytic cell line THP-1. J. Immunol. 150:1993;5604-5613
39. Du C., Sriram S. Induction of interleukin-12/p40 by superantigens in macrophages is mediated by activation of nuclear factor-kappaB. Cell. Immunol. 199:2000;50-57
40. Tai H.H., Ensor C.M., Tong M., Zhou H., Yan F. Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediators. 68-69:2002;483-493
41. Erickson K.L., Howard A.D., Chakrabarti R., Hubbard N.E. Alteration of platelet activating factor-induced macrophage tumoricidal response, IA expression, and signal transduction by N-3 fatty acids. Adv. Exp. Med. Biol. 407:1997;371-378
42. Snyder D.S., Beller D.I., Unanue E.R. Prostaglandins modulate macrophage Ia expression. Nature. 299:1982;163-165